Israeli cornea treatment co EyeYon raises $25m

Israeli cornea treatment co EyeYon raises $25m
The Israeli company will use the capital to expand clinical trials to treat corneal endema.
Israeli medical device company EyeYon Medical EyeYon Medical today announced the completion of a $25 million Series C financing round, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund, together with Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, Pontifax and Diamond BioFund. The latest round brings the total amount of capital raised by the company to $36 million.
EyeYon Medical, which was founded in 2011 by Dr. Ofer Daphna, CEO Nahum Ferera, and Dr. Arie Marcovich, develops advanced technology to treat acute ophthalmic problems.

Related Keywords

China ,Israel ,Israeli ,Nahum Ferera ,Arie Marcovich ,Life Science Fund ,Fund Quark Venture ,Global Health Sciences ,Eyeyon Medical ,Science Fund ,Quark Venture ,Yon Medical ,Ofer Daphna ,சீனா ,இஸ்ரேல் ,இஸ்ரேலி ,வாழ்க்கை அறிவியல் நிதி ,நிதி குவார்க் துணிகர ,உலகளாவிய ஆரோக்கியம் அறிவியல் ,அறிவியல் நிதி ,குவார்க் துணிகர ,யோன் மருத்துவ ,